Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Vaptor 20mg and Crestor 20mg in Healthy Male Subjects
NCT05637060Completed
- Sponsor
- University of Karachi
- Start
- Nov 2022
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of rosuvastatin in hypercholesterolemia (2 arms), sponsored by University of Karachi. Primary endpoints: Maximum plasma concentration, Time to reach maximum plasma concentration and 1 more. Started Nov 2022; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT05637060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05637060.